Professor Kim Dalziel is Head of Melbourne Health Economics at Melbourne School of Population and Global Health at The University of Melbourne. She is co-Group Leader in Health Services and Economics at the Murdoch Children’s Research Institute. She was awarded an NHMRC Investigator Award (2021-25) and is a Dame Kate Campbell Fellow in Research Excellence with the University of Melbourne (2020-24). She has Masters and PhD qualifications in Health Economics and specialises in child health economic evaluation including alongside clinical trials.

Professor Dalziel leads health economics components of NHMRC projects and programs including neonatal medicine (with a combined total NHMRC funding >$50.8m, last 5 years; $2.8m health economics). She is lead health economist on 6 completed (including 2 neonatal trials) and 18 current clinical trials (including a further 7 neonatal trials). She provides health economics consultations to the IMPACT neonatal trial network and is lead Health Economist for the PLATIPUS neonatal adaptive trials platform. Prof Dalziel collaborates with Oxford University, National Perinatal Epidemiology Unit (NPEU) and Michigan University. She has published over 110 papers and has made significant contributions to the area of economic evaluation alongside pediatric clinical trials, publishing in NEJM and Annals of Emergency Medicine. Her economic evaluation methods research is published in leading economics journals Health Economics, Value in Health, and PharmacoEconomics. She is founding lead of the International Health Economics Association (iHEA) Child Health and Wellbeing Special Interest Group and a member of the Professional Society ISPOR Best Practices Taskforce Leadership on child quality of life.